MANUFACTURERS LIFE INSURANCE COMPANY, THE - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$923,571
+2.4%
20,082
+27.9%
0.00%0.0%
Q2 2023$902,336
+54.6%
15,701
+0.9%
0.00%
Q1 2023$583,500
+34.4%
15,560
+0.4%
0.00%
Q4 2022$434,058
-1.0%
15,491
-0.7%
0.00%
Q3 2022$438,388
-18.9%
15,601
+0.4%
0.00%
Q2 2022$540,637
-2.4%
15,540
+0.7%
0.00%
Q1 2022$553,793
+21.2%
15,426
-21.5%
0.00%
Q4 2021$457,000
+17.8%
19,642
-3.9%
0.00%
Q3 2021$388,000
-11.2%
20,436
-5.8%
0.00%
Q2 2021$437,000
+10.4%
21,695
+0.3%
0.00%
Q1 2021$396,000
-10.6%
21,633
-1.9%
0.00%
Q4 2020$443,000
+8.8%
22,041
+1.6%
0.00%
Q3 2020$407,000
-15.2%
21,6980.0%0.00%
Q2 2020$480,000
+37.1%
21,698
-7.9%
0.00%
Q1 2020$350,000
-18.4%
23,561
+6.1%
0.00%
Q4 2019$429,000
-8.3%
22,214
-4.0%
0.00%
-100.0%
Q3 2019$468,000
-4.7%
23,131
-0.5%
0.00%0.0%
Q2 2019$491,000
+1.7%
23,243
-1.7%
0.00%0.0%
Q1 2019$483,000
+3.9%
23,644
+1.2%
0.00%0.0%
Q4 2018$465,000
-2.5%
23,361
-5.7%
0.00%0.0%
Q3 2018$477,000
+11.7%
24,780
-11.2%
0.00%
Q2 2018$427,000
-18.0%
27,913
+0.5%
0.00%
-100.0%
Q1 2018$521,000
-5.3%
27,787
-2.8%
0.00%0.0%
Q4 2017$550,000
+7.8%
28,600
+0.0%
0.00%0.0%
Q3 2017$510,000
-0.4%
28,588
-0.4%
0.00%0.0%
Q2 2017$512,000
+24.3%
28,701
+1.1%
0.00%0.0%
Q1 2017$412,000
-10.2%
28,389
+13.7%
0.00%0.0%
Q4 2016$459,000
-4.4%
24,958
-1.4%
0.00%0.0%
Q3 2016$480,000
+17.6%
25,314
-0.1%
0.00%0.0%
Q2 2016$408,000
+56.3%
25,337
+16.0%
0.00%
Q1 2016$261,000
-16.3%
21,845
-0.4%
0.00%
Q4 2015$312,000
+24.8%
21,935
+2.5%
0.00%
Q3 2015$250,000
-32.8%
21,394
+1.1%
0.00%
Q2 2015$372,000
+383.1%
21,158
+311.8%
0.00%
Q1 2015$77,000
+381.2%
5,138
+282.9%
0.00%
Q4 2014$16,000
+433.3%
1,342
+364.4%
0.00%
Q3 2014$3,0002890.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders